Paclitaxel Prodrug Enables Glutathione Depletion to Boost Cancer Treatment
ACS Nano · 01.10.2024 · 18 (39) · 26690-26703
DOI: 10.1021/acsnano.4c06399 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 20.09.2024. Verfasst von Biyou Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China. Hauptthemen laut MEDLINE: Prodrugs, Paclitaxel, Glutathione. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Natural Science Foundation of Jilin Province, National Natural Science Foundation of China, Scientific Research Foundation of the First Hospital of Jilin University.
Abstract (Originalsprache)
Herein, we constructed a paclitaxel (PTX) prodrug (PA) by conjugating PTX with acrylic acid as a cysteine-depleting agent. The as-synthesized PA can assemble with diacylphosphatidylethanolamine-PEG2000 to form stable nanoparticles (PA NPs). After endocytosis into cells, PA NPs can specifically react with cysteine and trigger release of PTX for chemotherapy. On the other hand, the depletion of cysteine can greatly downregulate the intracellular content of glutathione and lead to oxidative stress outburst-provoking ferroptosis. The released PTX can elicit antitumor immune response by inducing immunogenic cell death, thus promoting dendritic cells maturation and cascaded cytotoxic T lymphocytes activation, which not only produces a robust immunotherapy effect but also synergizes the ferroptosis therapy by inhibiting cysteine transport via the release of interferon-γ in the activated immune system. As a result, PA NPs exhibit favorable in vitro and in vivo antitumor performance with reduced systemic toxicity. Our work highlights the potential of simple molecular design of prodrugs for enhancing the therapeutic efficacy toward malignant cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, P. R. China.
- Department of Thyroid Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin 130021, P. R. China.
ORCID-Profile: Zhigang Xie, Xuesi Chen
Förderung
- Natural Science Foundation of Jilin Province
- National Natural Science Foundation of China
- Scientific Research Foundation of the First Hospital of Jilin University
Zitieren
APA
Zhang, B., Zhou, S., Lu, S., Xiang, X., Yao, X., Lei, W., Pei, Q., Xie, Z., & Chen, X. (2024). Paclitaxel Prodrug Enables Glutathione Depletion to Boost Cancer Treatment. ACS Nano, 18(39), 26690-26703. https://doi.org/10.1021/acsnano.4c06399
Vancouver
Zhang B, Zhou S, Lu S, Xiang X, Yao X, Lei W, et al. Paclitaxel Prodrug Enables Glutathione Depletion to Boost Cancer Treatment. ACS Nano. 2024;18(39):26690-26703. doi:10.1021/acsnano.4c06399
BibTeX
@article{Zhang2024,
author = {Zhang, Biyou and Zhou, Shiyu and Lu, Shaojin and Xiang, Xiujuan and Yao, Xiumin and Lei, Wentao and Pei, Qing and Xie, Zhigang and Chen, Xuesi},
title = {Paclitaxel Prodrug Enables Glutathione Depletion to Boost Cancer Treatment},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {39},
pages = {26690--26703},
doi = {10.1021/acsnano.4c06399}
}
EUVIMED